Case: 20-2134 Document: 70 Page: 1 Filed: 08/13/2021
NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
CEPHALON, INC., EAGLE PHARMACEUTICALS,
INC., TEVA PHARMACEUTICALS
INTERNATIONAL GMBH,
Plaintiffs-Appellees
v.
SLAYBACK PHARMA LLC, FRESENIUS KABI USA,
LLC
Defendants
APOTEX INC., APOTEX CORP., MYLAN
LABORATORIES LIMITED,
Defendants-Appellants
______________________
2020-2134, 2020-2137
______________________
Appeals from the United States District Court for the
District of Delaware in Nos. 1:17-cv-01154-CFC, 1:17-cv-
01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC,
Judge Colm F. Connolly.
______________________
JUDGMENT
______________________
DAVID I. BERL, Williams & Connolly LLP, Washington,
DC, argued for all plaintiffs-appellees. Plaintiffs-appellees
Case: 20-2134 Document: 70 Page: 2 Filed: 08/13/2021
Cephalon, Inc., Teva Pharmaceuticals International
GmbH also represented by ADAM HARBER, MATTHEW
LACHMAN, SHAUN PATRICK MAHAFFY, BEN PICOZZI.
DANIEL BROWN, Latham & Watkins LLP, New York,
NY, for plaintiff-appellee Eagle Pharmaceuticals, Inc. Also
represented by GABRIEL K. BELL, Washington, DC;
KENNETH G. SCHULER, MARC NATHAN ZUBICK, Chicago, IL.
STEVEN ERIC FELDMAN, Hahn Loeser & Parks, LLP,
Chicago, IL, argued for defendants-appellants Apotex Inc.,
Apotex Corp. Also represented by DANIEL RONALD CHERRY,
JOHN CRAVERO, SHERRY LEE ROLLO.
NICOLE W. STAFFORD, Wilson, Sonsini, Goodrich &
Rosati, Austin, TX, argued for defendant-appellant Mylan
Laboratories Limited. Also represented by ADEN M.
ALLEN; DENNIS DONALD GREGORY, New York, NY; DAVID S.
STEUER, Palo Alto, CA.
______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, CLEVENGER, and TARANTO,
Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
August 13, 2021 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court